Study Will Identify Lung Cancer Patients For Upfront Iressa Treatment

Earlier this year researchers at two Boston hospitals announced their discovery of a genetic marker that could predict which lung cancers would respond to treatment with the targeted-therapy drug Iressa (gefitinib). Now members of the same teams have launched a study using this marker to identify at the outset patients most likely to respon...

Continue to Study Will Identify Lung Cancer Patients For Upfront Iressa Treatment on ScienceDaily Headlines: Health & Medicine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz